STUDIES AND REPORTS

APMGR represents its members’ viewpoint on the generic medicine industry from Romania and its regulatory framework. In this respect, APMGR wants to promote and support the development of the generic medicine industry in a very competitive environment.

The main objective of the member companies is to provide suitable medicines to Romanian patients at the right moment, in order to improve the quality of life.

In developing its activity APMGR is in permanent dialogue with national and European authorities, at the parliament and governmental level.

Ce este nevoie sa stiu despre Medicamentele Biosimilare – Informatii pentru pacienti

2016/2017

COMISIA EUROPEANA

The role of generic medicines in sustaining healthcare systems: a European perspective

16 June 2015

REPORT IMS HEALTH

Clawback Tax: how to apply and what is the impact on the producers of generic medicines

10 March 2015

INFOGRAPHIC

Clawback tax blocks access to treatment for thousands of patients, increases health expenditure by the disappearance of available drugs and destroy local pharmaceutical industry

10 July 2014

PRESENTATION

The European Biosimilars Group calls upon national authorities and medical societies to actively engage in reducing the knowledge gap about biosimilar medicines

3 April 2014

EGA PRESS RELEASE

EGA calls for single market measures to remove barriers to generic medicines

27 March 2014

EGA PRESS RELEASE

Remove barriers to competition & free trade to boost the generic medicines industry

19 March 2014

EGA PRESS RELEASE

 
PROTOCOL OF COOPERATION on Medicine Counterfeiting between APMGR, producers and distributors of medicines and public authorities

18 March 2014

PROTOCOL OF COOPERATION

 
EGA’S NEW VISION FOR THE GENERICE MEDICINES INDUSTRY , based on 5 pillars structure.

February 2014

 

 
The Conclusions of the European Union Council’s Working Party on Public Health: “Reflection process: Towards modern, responsive and sustainable health systems”

December 2013

 

 
WHITE PAPER ON THE BENEFITS BROUGHT BY GENERIC MEDICINES: social and economic perspectives

September 2013

 

 
PROTOCOL OF COOPERATION between the Ministry of Health and APMGR on increasing access to pharmaceutical treatment for Romanian patients, while allowing efficient public spending and encouraging the development of the local pharmaceutical industry

30 April 2013

PROTOCOL OF COOPERATION

 
Industrial policy: making Europe a hub for manufacturing of generic and biosimilar medicines

January 2013

EGA REPORT

 
THE ROMANIAN GENERIC MEDICINE INDUSTRY – between regional development and survival on the local market

25 September 2012

 

 
INNOVATION PARADIGM IN PHARMACY INDUSTRY

24 April 2012

 

 
APMGR PROPOSALS on regulating in Framework Agreement 2012 for medicine prescription as well as on Trade Name (DC) as International Joint Name (DCI) in the purpose of increasing population access to medicine and stimulate generic pharma industry.

8 April 2012

 

 
APMGR PROPOSALS on health system improvement.

5 March 2012

 

 
EFFECTS OF NEW CONTRIBUTION TO FINANCE SOME EXPENSES IN HEALTH (CLAW BACK TAX )

5 March 2012

 

 
APMGR PROPOSALS on improving the quality of legislative and administrative frame in health and increasing population access to medicine , as well as encouraging the local pharma industry

14 December 2011